我院在执行2012版《国家基本药物目录》中出现的问题和困惑

Exploration of Problems and Confusion in Implementing National Essential Medicine List(2012 Edition)in Our Hospital

目的:为促进我国国家基本药物制度的全面实施和完善提供参考。方法:通过医院信息系统(HIS)收集我院2013年全年的药品品种、用药金额等信息并进行统计分析。结果:按2012版《国家基本药物目录》(下简称《目录》)统计,我院基本药物品种配备率和销售额占比均较按2009版《目录》统计明显下降;眼科专科用药基本药物采购率达80%,但眼科专科用药销售额中基本药物占比仅为4.13%,销售额居前10位的眼科专科用药中仅左氧氟沙星滴眼液在《目录》内;降眼压类药中销售份额最大的前列腺素类似物在《目录》中未收载。结论:《目录》中收载的眼科等专科用药品种少、品规局限,部分指南或共识推荐的品种未收录,难以满足医院专科用药的需求。因此,在今后修订《目录》时,应考虑适当增加专科用药品种或品规,以更好地满足临床药物需求。

OBJECTIVE：To provide reference for the full implementation and improvement of national essential medicine system in our country. METHODS：Through the hospital information system（HIS）,the drug varieties,consumption sum and other information in our hospital in 2013 were collected and statistically analyzed. RESULTS：According to the statistics of National Essential Medicine List（NEML）（2012 edition）（hereinafter referred to as List）,compared with NEML（2009 edition）,the proportions of varieties rate and sales amount of essential medicines were significantly decreased;procurement rate of ophthalmic drugs was reached 80%,but the proportion of sales amount of essential medicines in ophthalmic drugs was only 4.13%,there was only levofloxacin eye drop in the NEML among the top 10 ophthalmic drugs;the largest sales amount drug（prostaglandin analogs）among the IOP-lowering drugs was not collected by NEML. CONCLUSIONS：Specialty drugs（ophthalmic clrugs,etc.）collected by NEML have less varieties and limited commodities regulations. Parts of the relevant guidelines or consensus recommended varieties are not collected so that it is difficult to meet the demands of the hospital specialty drugs. So,the government should consider increasing drug varieties or commodities regulations to meet clinical demands when revise NEML in future.